Overview Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females Status: Terminated Trial end date: 2009-07-01 Target enrollment: Participant gender: Summary PK and safety profile of Proellex® in females with various stages of impaired renal function Phase: Phase 1/Phase 2 Details Lead Sponsor: Repros Therapeutics Inc.